Long-term outcome according to randomization for maintenance treatment
| . | ATRA . | No maintenance . | ATRA+CT . | CT alone . | P . |
|---|---|---|---|---|---|
| No. of patients | 76 | 79 | 129 | 117 | |
| Relapse | |||||
| No. | 26 | 35 | 18 | 29 | < .001 |
| 10-year CI | 33.0% | 43.2% | 13.4% | 23.4% | |
| EFS | |||||
| Events | 28 | 40 | 22 | 33 | < .001 |
| 10-year EFS | 62.9% | 51.4% | 79.7% | 72.6% | |
| Survival | |||||
| Deaths | 9 | 22 | 7 | 8 | < .001 |
| 10-year OS | 88.0% | 74.4% | 94.4% | 93.4% |
| . | ATRA . | No maintenance . | ATRA+CT . | CT alone . | P . |
|---|---|---|---|---|---|
| No. of patients | 76 | 79 | 129 | 117 | |
| Relapse | |||||
| No. | 26 | 35 | 18 | 29 | < .001 |
| 10-year CI | 33.0% | 43.2% | 13.4% | 23.4% | |
| EFS | |||||
| Events | 28 | 40 | 22 | 33 | < .001 |
| 10-year EFS | 62.9% | 51.4% | 79.7% | 72.6% | |
| Survival | |||||
| Deaths | 9 | 22 | 7 | 8 | < .001 |
| 10-year OS | 88.0% | 74.4% | 94.4% | 93.4% |